Related Experiment Videos
Graft-versus-host disease
1Department of Oncology 3-121, Johns Hopkins Hospital, Baltimore, MD 21287, USA.
Current Opinion in Oncology
|March 1, 1997
Summary
Graft-versus-host disease (GVHD) remains a significant challenge in allogeneic bone marrow transplantation. This review examines how various transplant strategies impact GVHD occurrence and severity.
Area of Science:
- Hematology
- Immunology
- Transplantation Medicine
Background:
- Graft-versus-host disease (GVHD) is a primary complication limiting the success of allogeneic bone marrow transplantation.
- Current clinical strategies in bone marrow transplantation significantly influence GVHD incidence and outcomes.
Purpose of the Study:
- To review the impact of different allogeneic transplantation approaches on Graft-versus-host disease.
- To consolidate current understanding of GVHD pathophysiology and clinical management.
Main Methods:
- Literature review of studies addressing GVHD in allogeneic transplantation.
- Categorization of papers based on GVHD pathophysiology, acute/chronic forms, and specific transplant modalities.
Main Results:
- Allogeneic peripheral blood cell transplantation, donor leukocyte infusions, and unrelated bone marrow transplantation present distinct GVHD challenges.
- Understanding these impacts is crucial for optimizing transplant protocols.
Conclusions:
- GVHD remains a critical factor influencing allogeneic transplant outcomes.
- Further research into mitigating GVHD across diverse transplantation strategies is warranted.